Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow.


Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333

Informations de publication

Date de publication:
20 05 2023
Historique:
pmc-release: 20 05 2024
medline: 19 5 2023
pubmed: 15 2 2023
entrez: 14 2 2023
Statut: ppublish

Résumé

Cancer genetic risk assessment (CGRA) is recommended for women with ovarian cancer or high-risk breast cancer, yet fewer than 30% receive recommended genetic services, with the lowest rates among underserved populations. We hypothesized that compared with usual care (UC) and mailed targeted print (TP) education, CGRA uptake would be highest among women receiving a phone-based tailored risk counseling and navigation intervention (TCN). In this three-arm randomized trial, women with ovarian or high-risk breast cancer were recruited from statewide cancer registries in Colorado, New Jersey, and New Mexico. Participants assigned to TP received a mailed educational brochure. Participants assigned to TCN received the mailed educational brochure, an initial phone-based psychoeducational session with a health coach, a follow-up letter, and a follow-up navigation phone call. Participants' average age was 61 years, 25.4% identified as Hispanic, 5.9% identified as non-Hispanic Black, and 17.5% lived in rural areas. At 6 months, more women in TCN received CGRA (18.7%) than those in TP (3%; odds ratio, 7.4; 95% CI, 3.0 to 18.3; TCN increased CGRA uptake in a group of geographically and ethnically diverse high-risk breast and ovarian cancer survivors. Remote personalized interventions that incorporate evidence-based health communication and behavior change strategies may increase CGRA among women recruited from statewide cancer registries.

Identifiants

pubmed: 36787512
doi: 10.1200/JCO.22.00751
pmc: PMC10414736
doi:

Banques de données

ClinicalTrials.gov
['NCT03326713']

Types de publication

Journal Article Randomized Controlled Trial Research Support, U.S. Gov't, P.H.S. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2767-2778

Subventions

Organisme : NCI NIH HHS
ID : K99 CA256043
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA072720
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201800014C
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA211625
Pays : United States
Organisme : NCI NIH HHS
ID : R00 CA256043
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201800014I
Pays : United States

Références

Am J Prev Med. 2010 Jul;39(1):1-14
pubmed: 20547275
J Pers Med. 2020 Sep 24;10(4):
pubmed: 32987879
Health Psychol. 2010 Nov;29(6):583-93
pubmed: 21090893
Am J Prev Med. 2016 Jul;51(1):1-11
pubmed: 26810358
JAMA Netw Open. 2020 Oct 1;3(10):e2022874
pubmed: 33119106
Patient Educ Couns. 2021 Jun;104(6):1325-1334
pubmed: 33390305
Cancer. 2018 Aug 1;124(15):3105-3117
pubmed: 29669169
N Engl J Med. 2017 Aug 10;377(6):523-533
pubmed: 28578601
Am J Epidemiol. 2019 May 1;188(5):928-939
pubmed: 30689685
Eur J Med Genet. 2019 May;62(5):357-367
pubmed: 30553023
Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):45-52
pubmed: 22068288
J Clin Oncol. 2012 Jul 20;30(21):2654-63
pubmed: 22711857
J Racial Ethn Health Disparities. 2020 Oct;7(5):874-879
pubmed: 32026286
J Health Psychol. 2019 Aug;24(9):1221-1232
pubmed: 28810422
J Genet Couns. 2021 Jun;30(3):730-741
pubmed: 33222313
Mayo Clin Proc. 2019 Jun;94(6):1084-1098
pubmed: 31171119
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
Patient Educ Couns. 2022 Jun;105(6):1488-1494
pubmed: 34649750
J Natl Cancer Inst. 2014 Nov 05;106(12):
pubmed: 25376862
Genet Med. 2018 Sep;20(9):985-994
pubmed: 29300376
Psychooncology. 2019 May;28(5):980-988
pubmed: 30883986
J Clin Oncol. 2014 May 20;32(15):1547-53
pubmed: 24567435
Ann Intern Med. 2017 Jul 4;167(1):40-47
pubmed: 28630973
Nat Rev Cancer. 2016 Sep;16(9):599-612
pubmed: 27515922
Am J Prev Med. 2017 Sep;53(3):363-372
pubmed: 28676254
J Cancer Educ. 2021 Feb;36(1):72-84
pubmed: 31402434
Am J Prev Med. 2015 Dec;49(6 Suppl 5):S528-35
pubmed: 26590648
BMC Health Serv Res. 2018 Mar 7;18(1):165
pubmed: 29514700
J Clin Oncol. 2017 Jul 10;35(20):2329-2337
pubmed: 28398847
J Psychosoc Oncol. 2010;28(5):470-89
pubmed: 20730660
Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):109-17
pubmed: 23118143
JAMA. 2010 Sep 1;304(9):967-75
pubmed: 20810374
BMC Med Res Methodol. 2012 Apr 10;12:46
pubmed: 22489953
J Gen Intern Med. 2008 May;23(5):561-6
pubmed: 18335281
BMC Public Health. 2020 May 1;20(1):603
pubmed: 32357943
J Clin Oncol. 2014 Sep 1;32(25):2758-64
pubmed: 25071111
BMC Public Health. 2017 May 25;17(1):503
pubmed: 28545429
MMWR Surveill Summ. 2017 Sep 08;66(15):1-11
pubmed: 28880857
Med Decis Making. 2020 Jul;40(5):555-581
pubmed: 32659154
BMC Med Res Methodol. 2014 Dec 19;14:136
pubmed: 25524532
Genome Med. 2014 Feb 26;6(2):16
pubmed: 24571651
J Cancer Surviv. 2016 Aug;10(4):674-85
pubmed: 26744339
J Natl Compr Canc Netw. 2021 Jan 06;19(1):77-102
pubmed: 33406487
Gynecol Oncol. 2015 Jul;138(1):109-14
pubmed: 25933682
Patient Educ Couns. 2013 Dec;93(3):488-95
pubmed: 24007767
JAMA Oncol. 2018 Jun 1;4(6):876-879
pubmed: 29710084
Int J Gynecol Cancer. 2013 Mar;23(3):431-6
pubmed: 23354368
J Registry Manag. 2014 Fall;41(3):103-12
pubmed: 25419602
Psychooncology. 2012 Sep;21(9):993-1002
pubmed: 21671305
J Clin Oncol. 2014 Mar 1;32(7):654-62
pubmed: 24449229
Contemp Clin Trials. 2018 Oct;73:123-135
pubmed: 30236776
Cancer. 2011 Dec 1;117(23):5334-43
pubmed: 21792861
J Health Dispar Res Pract. 2019 Fall;12(3):35-47
pubmed: 32995070
Psychol Bull. 2007 Jul;133(4):673-93
pubmed: 17592961
J Community Genet. 2018 Jan;9(1):81-92
pubmed: 28971318
J Genet Couns. 2017 Jun;26(3):480-490
pubmed: 27496122
J Health Commun. 2013;18(5):543-62
pubmed: 23448232
J Cancer Educ. 2023 Feb;38(1):42-49
pubmed: 34523076
Genet Epidemiol. 2018 Feb;42(1):117-122
pubmed: 29193313
Expert Rev Mol Diagn. 2017 Jan;17(1):57-70
pubmed: 27910721
J Gen Intern Med. 2021 Jan;36(1):35-42
pubmed: 32720237
Int J Colorectal Dis. 2017 Sep;32(9):1345-1348
pubmed: 28664346
J Genet Couns. 2017 Aug;26(4):697-715
pubmed: 27826805
J Clin Oncol. 2016 Aug 20;34(24):2914-24
pubmed: 27325848
J Community Genet. 2020 Jan;11(1):85-99
pubmed: 31104207
J Health Commun. 2005;10 Suppl 1:53-64
pubmed: 16377600
N Engl J Med. 2018 Aug 23;379(8):753-763
pubmed: 30110579
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:3-14
pubmed: 27743768

Auteurs

Anita Y Kinney (AY)

Rutgers University School of Public Health, Rutgers University, The State University of New Jersey, Newark, NJ.
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

Scott T Walters (ST)

University of North Texas Health Science Center, Fort Worth, TX.

Yong Lin (Y)

Rutgers University School of Public Health, Rutgers University, The State University of New Jersey, Newark, NJ.

Shou-En Lu (SE)

Rutgers University School of Public Health, Rutgers University, The State University of New Jersey, Newark, NJ.

Arreum Kim (A)

Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

Julianne Ani (J)

Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

Emily Heidt (E)

Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

Circe J G Le Compte (CJG)

Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

Denalee O'Malley (D)

Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
School of Medicine, Rutgers University, The State University of New Jersey, Newark, NJ.

Antoinette Stroup (A)

Rutgers University School of Public Health, Rutgers University, The State University of New Jersey, Newark, NJ.
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

Lisa E Paddock (LE)

Rutgers University School of Public Health, Rutgers University, The State University of New Jersey, Newark, NJ.
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

Sherry Grumet (S)

Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

Tawny W Boyce (TW)

UNM Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM.

Deborah L Toppmeyer (DL)

Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

Jean A McDougall (JA)

School of Medicine, University of New Mexico, Albuquerque, NM.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH